Research in RCM is ongoing, with a focus on understanding the genetic and molecular basis of the disease. Advances in gene therapy, regenerative medicine, and novel pharmacological agents hold promise for improving outcomes in neonates with RCM. Collaborative efforts between researchers, clinicians, and patient advocacy groups are essential to drive progress in this field.
